Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 36 citing Bodaghi: Efficacy of interferon alpha in the treatment of refractory and sight threatening.... (0.11 sec) 

Anti-TNF therapy in the management of Behcet's disease--review and basis for …

- oxfordjournals.org
PP Sfikakis, N Markomichelakis, E Alpsoy, S … - Rheumatology, 2007 - Br Soc Rheumatology
Behçet's disease (BD) is a multisystem, chronic-relapsing, inflammatory
disorder classified among the vasculitides [1, 2]. It has a worldwide
distribution being more prevalent in the Middle East, Far East and the ...
Cited by 59 - Related articles - BL Direct - All 5 versions

EULAR recommendations for the management of Behcet disease


G Hatemi, A Silman, D Bang, B Bodaghi, AM … - British Medical Journal, 2008 - ard.bmj.com
Methods: The multidisciplinary expert committee, a task force of the EULAR
Standing Committee for Clinical Affairs (ESCCA), consisted of nine
rheumatologists (one who was also a clinical epidemiologist and one also a ...
Cited by 27 - Related articles - All 3 versions

Biologics in the treatment of uveitis

- duanessolution.com
FR Imrie, AD Dick - Current Opinion in Ophthalmology, 2007 - journals.lww.com
Recent findings: The anti-tumour necrosis factor-α infliximab and adalimumab
have demonstrated significant efficacy in controlling uveitis associated with
seronegative spondyloarthropathies and juvenile idiopathic arthritis; ...
Cited by 18 - Related articles - BL Direct - All 4 versions

Ocular features of Behçet's disease: an international collaborative study


N Kitaichi, A Miyazaki, D Iwata, S Ohno, MR … - British Journal of Ophthalmology, 2007 - bjo.bmj.com
Results: 25 eye centres in 14 countries returned questionnaires on prevalent
cases in 2006. Clinical data were analysed on 1,465 patients with ocular
lesions. Recurrent oral aphthous ulcers were reported in 94.5%, skin ...
Cited by 16 - Related articles - BL Direct - All 3 versions

Nonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitis


FR Imrie, AD Dick - Current Opinion in Ophthalmology, 2007 - journals.lww.com
Purpose of review This review summarizes current nonsteroidal drug therapies for
noninfectious posterior and intermediate uveitis. Recent findings Continuing
evidence shows that second-line agents including antimetabolites, T-cell ...
Cited by 9 - Related articles - BL Direct - All 2 versions

Inflammatory cystoid macular edema

- prsjournal.com
A Rothova - Current Opinion in Ophthalmology, 2007 - journals.lww.com
Purpose of review The aim of this article is to update our current understanding
and management of inflammatory cystoid macular edema. Recent findings Cystoid
macular edema is a common cause of visual loss in uveitis, which occurs ...
Cited by 9 - Related articles - BL Direct - All 6 versions

Efficacy and safety of interferon-{alpha} in the treatment of corticodependent uveitis of …

- oxfordjournals.org
S Guillaume-Czitrom, C Berger, C Pajot, B … - Rheumatology, 2007 - Br Soc Rheumatology
Department of Paediatrics and Paediatric Rheumatology, Bicêtre Hospital, Le
Kremlin-Bicêtre, 1 Department of Paediatrics, Saint-Etienne Hospital, Saint
Priest en Jarez, 2 Department of Paediatrics, Purpan Hospital, Toulouse, 3 ...
Cited by 8 - Related articles - BL Direct - All 3 versions

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated …


L Krause, A Altenburg, U Pleyer, AK Köhler, … - The Journal of rheumatology, 2008 - jrheum.org
Personal non-commercial use only. The Journal of Rheumatology Copyright © 2008.
All rights reserved. ... Longterm Visual Prognosis of Patients with Ocular ...
LOTHAR KRAUSE, ANDREAS ALTENBURG, UWE PLEYER, ANNE-KATRIN KÖHLER, CHRISTOS ...
Cited by 6 - Related articles - BL Direct - All 8 versions

Immunosuppressive therapy for ocular diseases

- duanessolution.com
A Jap, SP Chee - Current Opinion in Ophthalmology, 2008 - journals.lww.com
Recent findings: The biologics in current use include antitumour necrosis
factor-α agents (infliximab, etanercept and adalimumab), cytokine receptor
antibodies (daclizumab) and interferon-α2a. They are effective and ...
Cited by 6 - Related articles - All 4 versions

Management of Behcet's disease: a systematic literature review for the EULAR evidence …


G Hatemi, A Silman, D Bang, B Bodaghi, AM … - British Medical Journal, 2008 - ard.bmj.com
Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ...
Cited by 4 - Related articles - All 2 versions


Result Page: 

1

2

3

4

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google